• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体 1 促进小鼠肾缺血再灌注损伤中小血管功能障碍和肾小管损伤。

Protease-Activated Receptor 1 Contributes to Microcirculation Failure and Tubular Damage in Renal Ischemia-Reperfusion Injury in Mice.

机构信息

Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Department of Pharmacology, Kagawa University, Kagawa, Japan.

出版信息

Biomed Res Int. 2021 Feb 23;2021:6665714. doi: 10.1155/2021/6665714. eCollection 2021.

DOI:10.1155/2021/6665714
PMID:33681367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925038/
Abstract

Ischemia-reperfusion- (IR-) induced kidney injury is difficult to avoid during renal transplantation and robot-assisted partial nephrectomy. Renal IR injury is characterized by tubular damage, microcirculation failure, and inflammation, which coordinately augment renal injury; however, no specific treatment is available for these conditions. Protease-activated receptor-1 (PAR-1) and its ligand, thrombin, are involved in coagulation and were shown to be associated with epithelial cell injury. Here, we hypothesized that PAR-1 exaggerated renal IR-induced tubular cell damage and microcirculation failure and that pharmacological inhibition of PAR-1 by Q94 could prevent these injuries. Renal warm IR increased the expression of PAR-1 in the renal tubules. Q94 attenuated renal IR-induced changes and histopathological damage. Microcirculation failure analyzed by congestion in the histopathology and blood cell flow examined by intravital multiphoton microscopy were suppressed by Q94 treatment. Q94 also dramatically increased tubular cell proliferation despite the lower renal damage. Thrombin suppressed cell proliferation and induced apoptosis in the tubules; these effects were prevented by Q94 treatment. Taken together, PAR-1 was associated with renal IR injury. Inhibition of PAR-1 ameliorated injury possibly by improving renal microcirculation and tubular cell survival/proliferation.

摘要

缺血再灌注(IR)引起的肾损伤在肾移植和机器人辅助部分肾切除术过程中难以避免。肾 IR 损伤的特征是肾小管损伤、微循环衰竭和炎症,这些共同加重了肾损伤;然而,目前尚无针对这些情况的特定治疗方法。蛋白酶激活受体-1(PAR-1)及其配体凝血酶参与凝血,并与上皮细胞损伤有关。在这里,我们假设 PAR-1 可加重肾 IR 诱导的肾小管细胞损伤和微循环衰竭,而通过 Q94 抑制 PAR-1 可预防这些损伤。肾温热 IR 增加了肾小管中 PAR-1 的表达。Q94 减轻了肾 IR 诱导的变化和组织病理学损伤。组织病理学中通过充血分析的微循环衰竭和通过活体多光子显微镜检查的血细胞流被 Q94 治疗抑制。尽管肾损伤较低,Q94 仍显著增加了管状细胞的增殖。凝血酶抑制了肾小管中的细胞增殖并诱导细胞凋亡;这些作用通过 Q94 治疗得到预防。综上所述,PAR-1 与肾 IR 损伤有关。PAR-1 抑制可通过改善肾微循环和肾小管细胞存活/增殖来减轻损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/6c39da033b64/BMRI2021-6665714.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/aa73f82a4b7d/BMRI2021-6665714.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/e3a373d365e3/BMRI2021-6665714.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/a825f43a6730/BMRI2021-6665714.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/6c39da033b64/BMRI2021-6665714.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/aa73f82a4b7d/BMRI2021-6665714.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/e3a373d365e3/BMRI2021-6665714.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/a825f43a6730/BMRI2021-6665714.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af78/7925038/6c39da033b64/BMRI2021-6665714.004.jpg

相似文献

1
Protease-Activated Receptor 1 Contributes to Microcirculation Failure and Tubular Damage in Renal Ischemia-Reperfusion Injury in Mice.蛋白酶激活受体 1 促进小鼠肾缺血再灌注损伤中小血管功能障碍和肾小管损伤。
Biomed Res Int. 2021 Feb 23;2021:6665714. doi: 10.1155/2021/6665714. eCollection 2021.
2
Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine.肾缺血再灌注损伤后的蛋白质氧化和脂质过氧化:厄多司坦和N-乙酰半胱氨酸的保护作用。
Urol Res. 2006 Feb;34(1):41-6. doi: 10.1007/s00240-005-0031-3. Epub 2006 Jan 21.
3
Preischemic Administration of Nonexpanded Adipose Stromal Vascular Fraction Attenuates Acute Renal Ischemia/Reperfusion Injury and Fibrosis.未扩增脂肪基质血管成分的缺血前给药可减轻急性肾缺血/再灌注损伤和纤维化。
Stem Cells Transl Med. 2016 Sep;5(9):1277-88. doi: 10.5966/sctm.2015-0223. Epub 2016 Jun 30.
4
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.组织因子缺乏和蛋白酶激活受体-1缺乏对肾缺血再灌注损伤具有保护作用。
Blood. 2007 Jan 15;109(2):577-83. doi: 10.1182/blood-2006-03-008870. Epub 2006 Sep 21.
5
Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.帕斯塔丁可预防肾缺血/再灌注和放射性造影剂给药后的肾损伤。
Am J Nephrol. 2012;36(3):278-86. doi: 10.1159/000341871. Epub 2012 Sep 7.
6
Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury.硫化氢加速肾缺血/再灌注损伤后肾小管的恢复。
Nephrol Dial Transplant. 2015 Sep;30(9):1497-506. doi: 10.1093/ndt/gfv226. Epub 2015 Jul 3.
7
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.PAR-1 拮抗剂 vorapaxar 可改善肾损伤和肾小管间质纤维化。
Clin Sci (Lond). 2020 Nov 13;134(21):2873-2891. doi: 10.1042/CS20200923.
8
Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury.在缺血再灌注损伤模型中,Par-4是肾小管细胞死亡的一种新型介质。
Am J Physiol Renal Physiol. 2007 Jan;292(1):F107-15. doi: 10.1152/ajprenal.00083.2006. Epub 2006 Aug 8.
9
Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase.MUC1 黏蛋白在肾缺血再灌注损伤中的双重作用:早期的肾保护作用,晚期的促纤维化作用。
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1336-1349. doi: 10.1016/j.bbadis.2017.03.023. Epub 2017 Mar 31.
10
Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.Caspase-3 是缺血再灌注损伤后微血管稀疏和肾纤维化的关键调节因子。
J Am Soc Nephrol. 2018 Jul;29(7):1900-1916. doi: 10.1681/ASN.2017050581. Epub 2018 Jun 20.

引用本文的文献

1
Retracted: Protease-Activated Receptor 1 Contributes to Microcirculation Failure and Tubular Damage in Renal Ischemia-Reperfusion Injury in Mice.撤回:蛋白酶激活受体1促成小鼠肾缺血再灌注损伤中的微循环衰竭和肾小管损伤。
Biomed Res Int. 2024 Jan 9;2024:9765836. doi: 10.1155/2024/9765836. eCollection 2024.
2
Modifiable contributing factors to COVID-19: A comprehensive review.可改变的 COVID-19 致病因素:全面综述。
Food Chem Toxicol. 2023 Jan;171:113511. doi: 10.1016/j.fct.2022.113511. Epub 2022 Nov 28.
3
Lack of miRNA-17 family mediates high glucose-induced PAR-1 upregulation in glomerular mesangial cells.

本文引用的文献

1
Recombinant thrombomodulin prevents acute lung injury induced by renal ischemia-reperfusion injury.重组血栓调节蛋白可预防肾缺血再灌注损伤引起的急性肺损伤。
Sci Rep. 2020 Jan 14;10(1):289. doi: 10.1038/s41598-019-57205-0.
2
A mouse model of renal fibrosis to overcome the technical variability in ischaemia/reperfusion injury among operators.一种克服操作者间缺血/再灌注损伤技术变异性的肾纤维化小鼠模型。
Sci Rep. 2019 Jul 18;9(1):10435. doi: 10.1038/s41598-019-46994-z.
3
EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
miRNA-17 家族缺失介导高糖诱导肾小球系膜细胞 PAR-1 的上调。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Jan;395(1):77-85. doi: 10.1007/s00210-021-02184-1. Epub 2021 Nov 18.
4
Protease-Activated Receptor-1 Antagonist Protects Against Lung Ischemia/Reperfusion Injury.蛋白酶激活受体-1拮抗剂可预防肺缺血/再灌注损伤。
Front Pharmacol. 2021 Sep 30;12:752507. doi: 10.3389/fphar.2021.752507. eCollection 2021.
EGFR 通过 HIPK2 的过表达驱动 AKI 向 CKD 的进展。
Theranostics. 2019 Apr 13;9(9):2712-2726. doi: 10.7150/thno.31424. eCollection 2019.
4
Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.M1 极化巨噬细胞来源的外泌体通过激活巨噬细胞介导的炎症增强紫杉醇的抗肿瘤活性。
Theranostics. 2019 Feb 28;9(6):1714-1727. doi: 10.7150/thno.30716. eCollection 2019.
5
Glomerular filtrate proteins in acute cardiorenal syndrome.急性心肾综合征中的肾小球滤过蛋白。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.122130.
6
Corin Is Downregulated in Renal Ischemia/Reperfusion Injury and Is Associated with Delayed Graft Function after Kidney Transplantation.Corin 在肾缺血/再灌注损伤中下调,与肾移植后延迟肾功能恢复有关。
Dis Markers. 2019 Jan 14;2019:9429323. doi: 10.1155/2019/9429323. eCollection 2019.
7
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.钠-葡萄糖共转运蛋白 2 抑制剂通过血管内皮生长因子依赖性途径减轻小鼠肾损伤后的肾脏毛细血管损伤和纤维化。
Kidney Int. 2018 Sep;94(3):524-535. doi: 10.1016/j.kint.2018.05.002. Epub 2018 Jul 23.
8
Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury.有丝分裂后小管细胞的肥大和祖细胞的增殖在急性肾损伤后恢复肾功能。
Nat Commun. 2018 Apr 9;9(1):1344. doi: 10.1038/s41467-018-03753-4.
9
Combined therapy with gas gangrene antitoxin and recombinant human soluble thrombomodulin for Clostridium perfringens sepsis in a rat model.气性坏疽抗毒素与重组人可溶性血栓调节蛋白联合治疗大鼠产气荚膜梭菌败血症模型
Toxicon. 2018 Jan;141:112-117. doi: 10.1016/j.toxicon.2017.12.043. Epub 2017 Dec 12.
10
A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy.蛋白酶激活受体-1拮抗剂在肾病小鼠模型中可预防足细胞损伤。
J Pharmacol Sci. 2017 Sep 14. doi: 10.1016/j.jphs.2017.09.002.